According to The Insight Partners marketresearch study of Continuous Positive Airway Pressure (CPAP) Devices Market to2027 – Global Analysis and Forecast by Type and End User, the global continuous positive airway pressure (CPAP) devicesmarketis expected to reach US$ 4,481.41 million by2027 from US$ 2,462.86 million in 2019. The market isestimated to grow at a CAGR of 7.8% from 2020 to 2027. The report highlights trends prevailing in the global continuous positiveairway pressure (CPAP) devices market and the factors driving market along withthose that act as hindrances.
Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00002982/
Based on type, the global continuouspositive airway pressure (CPAP) devices market is segmented into automatic andmanual. The automatic segment held the largest share of the market in 2019 asthese are initially used for pressure titration. Auto-CPAP is set within a highand low-pressure range for the purpose of varying inhalation needs.Additionally, this technology has a sensitive algorithm that allows the machineto detect the inhalation pressure which patients need for with each breath.
The continuous positiveairway pressure (CPAP) devices marketis expected to grow owing to factors such asgrowing prevalence ofsleep apnearespiratory disorders rising number of geriatric population and increasing prevalence of obesity. technological advancement in continuouspositive airway pressure (CPAP) devices is likely to have a positive impact onthe market in the coming years.
3B Medical, Inc., Airing,Cardinal Health, DeVilbiss Healthcare LLC, Smiths Medical (Smiths Group Plc.),Koninklijke Philips N.V., Somnetics International, Inc. (Transcend), SleepnetCorporation, Circadiance, and ResMedare among the leading companies operatingin the continuous positive airway pressure (CPAP) devices market.
Technological Advancement in Continuous Positive AirwayPressure (CPAP) Devices
The launch of continuous positive airway pressure (CPAP) devices iscreating a dynamic competition among players to keep up their position in themarket. The players are coming up with multiple and advanced types of devices forbuyers in order to offer a wide range of alternatives in the field of treatmentof sleep apnea and respiratory disorder. For instance, in August 2016,ResMedlaunched an application called myAir, for continuous positive airwaypressure devices users to track sleep apnea treatment. With myAir, CPAP userscan track their treatment via an iOS system, which facilitates users to accesstheir daily sleep patterns and coaching tips. Furthermore, in April 2017,ResMed launched the world’s smallest CPAP called AirMini, to provide treatmentfor patients suffering from apnea. With Reset’s AutoSet, AirMini is presentwith a built-in humidification system. Additionally, in April 2017, RoyalPhilips launched DreamStation Go, which was the latest and smallest positiveairway pressure (PAP) developed to simplify travel for patients living withobstructive respiratory disorder.The company is into innovation forrespiratorycare types that serve the needs of patients with COPD and neuromusculardiseases.Moreover,in2019, ResMed havereleased new Types including AirFitF30,afull-facemaskwithminimal-contactcushion,andAirFitN30iandP30i,atop-of-headconnectednasalandpillowmask,respectively.
The report segments global continuous positive airwaypressure (CPAP) devices market as follows:
By End User